Abstract
The culprit is an 11-year-old creature known as the European Commission’s Clinical Trials Directive that apparently creates a mountain of bureaucratic red tape and overly stringent oversight, leading to an average 152-day delay in the start of trials. The consequence, many companies and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
